The third batch of Pfizer Inc.'s COVID-19 vaccine arrived in Japan on Monday as the country prepares to expand its inoculation program for health care workers.

The shipment of up to 526,500 doses of the Pfizer shot, the first vaccine against the novel coronavirus that Japan has approved for use, was delivered to Narita Airport from Belgium, where they were produced.

Including the shipment, the government has said it will receive up to 2.66 million doses, with six shots taken from a single vaccine bottle, in March alone.

As for vaccines from other drugmakers, Chief Cabinet Secretary Katsunobu Kato told a news conference Monday that a clinical study is underway in Japan for U.S. company Johnson & Johnson's single-dose vaccine, which the U.S. government approved for emergency use last week.

It is raising hopes for a simpler mass inoculation process, given that the two other U.S.-approved vaccines from Pfizer and Modern Inc. require two shots. Johnson & Johnson's vaccine can be stored for three months at normal refrigerator temperatures and has a two-year shelf-life when frozen.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW